Ohara Pharmaceutical Co., Ltd.

Ohara Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company that focuses on the development and manufacturing of orphan and generic drugs. The company is dedicated to providing dependable pharmaceuticals for the future of medicine, addressing unmet medical needs in areas such as primary cancers, hematologic cancers, and diseases of the central nervous system. Ohara combines its new drug and generic drug businesses, leveraging advanced technological capabilities to tackle challenges in orphan drug markets. In addition to its domestic operations, Ohara is actively expanding internationally. The company has entered into strategic alliances with various partners to enhance healthcare accessibility and public health standards. Notably, Ohara has collaborated with Fidson Healthcare Plc in Nigeria to bolster local drug production and reduce reliance on imported medicines. This partnership aims to improve the quality and affordability of healthcare solutions across Africa. Ohara's investment strategy includes supporting the growth of regional healthcare companies and addressing global health challenges. The company has invested in Revital Healthcare (EPZ) Limited, the largest manufacturer of medical devices in sub-Saharan Africa, to enhance production capacity for essential medical supplies. Through these initiatives, Ohara demonstrates its commitment to advancing healthcare infrastructure and contributing to the resolution of social issues through quality healthcare services.